✦ LIBER ✦

Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo

✍ Scribed by Hazama, S; Noma, T; Wang, F; Iizuka, N; Ogura, Y; Yoshimura, K; Inoguchi, E; Hakozaki, M; Hirose, K; Suzuki, T

Book ID: 110002325
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 402 KB
Volume: 80
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6690538

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dissimilar anti-tumour reactions induced

✍ Di Carlo, Emma; Meazza, Raffaella; Basso, Stefania; Rosso, Ombretta; Comes, Albe 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Interleukin (IL)-15 shares immuno-stimulatory properties with IL-2 and is a potent inducer of natural killer (NK) cell function. The major histocompatibility complex (MHC) class I-negative human small cell lung cancer (SCLC) cell line N592, engineered to express a modi®ed IL-15 cDNA (N592/IL-15), se

In vivo studies of cell-mediated and hum

In vivo studies of cell-mediated and humoral immune responses to adenovirus 12-induxced tumour cells

✍ R. C. Rees; C. W. Potter 📂 Article 📅 1973 🏛 Springer Vienna 🌐 English ⚖ 703 KB

In vivo splenic CD11c cells downregulate

In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine

✍ Cayeux, S; Bukarica, B; Buschow, C; Charo, J; Bunse, M; Dörken, B; Blankenstein, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 553 KB

Generation of an anti-tumour immune resp

Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression

✍ Richard G. Vile; Simon Castleden; John Marshall; Richard Camplejohn; Carol Upton 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 471 KB

Direct delivery of the herpes simplex virus thymidine kinase (HSVtk) gene, in combination with the prodrug ganciclovir (GC), has been used for the treatment of localised, inoperable tumours. Several groups have shown that when rodent tumours are ablated in vivo with suicide genes, anti-tumour immuni